A common question in pharmaceutical, biotechnology, and medical device laboratories is:
“Why does Analyst A consistently obtain different endotoxin results from Analyst B when using the same method?”
While endotoxin testing methods are validated and highly controlled, analyst-related variability can still influence assay performance. Small differences in technique, timing, sample handling, and procedural execution can affect Product Positive Control (PPC) recovery, endotoxin recovery, and overall test reliability.
Understanding these sources of variability can help laboratories improve consistency, reduce investigations, and strengthen confidence in bacterial endotoxin testing (BET) results.
In theory, yes.
When a method is properly validated and analysts are adequately trained, results should fall within an acceptable range of variation.
However, endotoxin assays are highly sensitive biological reactions. Even minor procedural differences can influence the outcome.
This does not necessarily mean one analyst is wrong. Instead, it may indicate variability within the testing process that should be understood and controlled.
Pipetting is one of the most common causes of analyst-to-analyst variation.
Small inaccuracies can significantly affect:
Examples include:
Even a small volume difference can affect recovery calculations.
Proper mixing is essential for uniform endotoxin distribution.
Variations may occur when analysts:
Poor mixing can result in inconsistent endotoxin concentrations throughout the sample.
Create a standardized mixing procedure and include it in the testing SOP.
Endotoxin testing often involves multiple timed steps.
Differences in timing can affect:
For example, one analyst may prepare and test immediately, while another may allow samples to sit for an extended period.
Define acceptable timing windows for critical steps.
Product Positive Controls rely on accurate spike preparation.
Variability may occur due to:
This can directly influence recovery performance.
Use standardized worksheets and independent verification of calculations.
Analysts may unknowingly introduce variability during sample handling.
Examples include:
Additional handling steps may increase endotoxin adsorption and recovery variability.
Minimize sample handling and follow validated procedures.
Sometimes variability occurs because different analysts interpret the same procedure differently.
Common examples include:
Even well-written SOPs may leave room for interpretation.
Review procedures regularly and clarify ambiguous instructions.
Analyst experience often affects consistency.
Experienced analysts may:
Newer analysts may require additional supervision and coaching.
Implement competency assessments and ongoing training programs.
Analysts working under different conditions may produce different results.
Examples include:
Although these factors are often overlooked, they can influence execution quality.
Maintain controlled testing environments and minimize interruptions.
Method suitability studies often reveal analyst-related variability because they involve multiple preparation and dilution steps.
Differences may appear in:
Consistent method suitability procedures are essential for reliable results.
Variability is sometimes discovered only because documentation differs between analysts.
Incomplete records can make investigations more difficult and mask the true source of variation.
Require complete and standardized documentation for every test.
Consider investigating analyst-related factors if you observe:
✓ Consistent differences between analysts
✓ Variable PPC recovery results
✓ Recovery fluctuations without product changes
✓ Repeated retesting by specific analysts
✓ Differences during method suitability studies
✓ Increased investigation frequency
Successful laboratories focus on standardization.
Key measures include:
Ensure SOPs clearly define every critical step.
Evaluate analysts regularly using practical demonstrations.
Provide refresher training and procedural updates.
Periodically observe testing practices to identify procedural drift.
Review recovery trends by analyst to identify recurring patterns.
Confirm that all analysts use calibrated equipment consistently.
During inspections, auditors may ask:
Being able to demonstrate a structured approach to analyst qualification helps strengthen confidence in the testing program.
Endotoxin testing is highly dependent on procedural consistency. Even when using the same method, differences in pipetting, mixing, timing, sample handling, interpretation, and experience can contribute to analyst-to-analyst variability.
By standardizing procedures, strengthening training programs, monitoring trends, and investigating variability proactively, laboratories can improve endotoxin testing consistency and reduce unnecessary investigations.
BIOENTAL supports pharmaceutical, biotechnology, medical device, and healthcare laboratories with endotoxin method suitability studies, analyst training support, troubleshooting assistance, recombinant endotoxin technologies, and endotoxin-free consumables to help improve BET reliability and consistency.
Recommended guides, troubleshooting resources, and validation insights for pharmaceutical, biotechnology, and medical device laboratories.
Need Assistance?